What this study does is beg some important questions.

Our study challenges that conventional wisdom.

The most obvious areas we want to examine are those in which there are overt moral controversies: sexual and reproductive health, end-of-life care.

The close ties between belief and behavior suggests that physicians are unlikely to reach agreement anytime soon about what is suitable.

We found no consensus among physicians about what is customary or appropriate. Despite efforts to standardize many aspects of the doctor-patient relationship, patients are likely to encounter very different approaches.

The initial results of this phase I/II study in RA are very encouraging. We are looking forward to the ongoing development of HuMax-CD20 in RA.